Professionally designed and constructed, the Momcozy nasal aspirator offers improved versatility and comfort when it comes to ...
The approval for the CRSwNP indication was based on data from the randomized, double-blind, placebo-controlled WAYPOINT trial.
Approval based on WAYPOINT Phase III results demonstrating reduced nasal polyp severity and nasal congestion, near-elimination of the need for surgery and significantly reduced systematic ...
Diwali, with AQI at 358. We got in touch with experts warn smog can trigger sinus problems, migraines, and long-term lung ...
The FDA approved tezepelumab-ekko (TEZSPIRE; AstraZeneca/Amgen) on Friday as an add-on maintenance treatment in patients aged ...
The U.S. Food and Drug Administration has approved Amgen and AstraZeneca's drug for a type of chronic inflammatory sinus ...
Amgen and AstraZeneca’s Tezspire (tezepelumab-ekko) gains FDA approval as an add-on maintenance therapy for patients aged 12 and older with inadequately controlled chronic rhinosinusitis with nasal ...
Investing.com -- AstraZeneca and Amgen have received European Union approval for Tezspire as an add-on therapy for adults ...
Sleep is a critical for one's wellbeing, however, according to the National Institutes of Health, 1 in 3 U.S. adults don't ...
Health officials have issued a stern warning to anyone experiencing a common Covid symptom, cautioning that ignoring the advice could lead to further complications.
Inhalers with menthol, camphor or eucalyptus should not be used on children or around infants. Read more at straitstimes.com. Read more at straitstimes.com.